Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of KRYS will rise by +10.22% over the next 2 Weeks and hit $197.97 by Wednesday, October 15, 2025. In that time frame, KRYS's share price is expected to range between $193.62 and $202.49.
BearishAverageBullishKRYS shares rose +1.16% in Thursday, October 2, 2025's trading session, rising from a previous close of $179.61 to move at $181.69. The stock demonstrated notable intraday movement (see KRYS's key stats for a full breakdown), fluctuating between $178.61 and $182.28, a +2.05% trading range. While recent weeks have seen some volatility, KRYS has managed to secure a +11.08% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 261.32K shares changing hands, 273.21K fewer than the previous session. This amounted to $47.48M in total market activity.
Will KRYS Continue Its Upward Trend?
According to analyst ratings and projections for KRYS, Krystal Biotech, Inc. shares are anticipated to increase by +10.27%, potentially reaching $202.49 per share by October 15, 2025. Short-term technical indicators currently suggest a neutral sentiment for KRYS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the KRYS stock forecast, now is a good time to buy KRYS stock because its current trading price is -8.22% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on KRYS covering social and institutional perspectives.
KRYS Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into KRYS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 70.83% to 81.67%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 59.65%, suggests a neutral medium-term outlook. However, the 100-day RSI, at 54.19%, maintains a neutral outlook for the long term. Insights into KRYS's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Krystal Biotech Short-Term Forecasts
KRYS Forecast For Next 5 Days
Our algorithm anticipates Krystal Biotech (KRYS) stock could hit $167.24 by Oct 09, 2025. This represents a -7.95% rise from today's price, following a +12.75% change over the past five days.
KRYS Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Krystal Biotech, Inc. (KRYS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $178.62, which would mean a -1.69% decrease from the current price of $181.69. Projections for this period range from a high of $200.31 to a low of $158.86.
KRYS Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Krystal Biotech's price over the next three months point to a rise. KRYS stock is expected to peak at $208.94 on Nov 11, 2025 after potentially dipping to $163.94 on Oct 10, 2025. On average, KRYS is likely to trade around $182.05 in the coming 90 days.
Krystal Biotech Stock Forecast 2025
Based on our predictive models, Krystal Biotech (KRYS) is expected to trade between $163.94 and $208.94 throughout 2025. This would result in an average price of $182.01, potentially offering investors a +0.18% return from current levels.
Krystal Biotech, Inc. Monthly Forecast 2025–2026
October 2025
According to our latest forecast models, Krystal Biotech, Inc. (KRYS) is positioned to show a strong performance in October 2025. The price is predicted to move between $163.94 and $191.58, settling at an average of $177.77. This could translate to a -2.16% loss.
November 2025
Based on current market signals, Krystal Biotech, Inc. is projected to trend november 2025. We forecast a trading range from $170.63 to $208.94, with a likely average price of $184.99. Investors could expect a potential return of +1.82%.
December 2025
Our predictive algorithms indicate Krystal Biotech, Inc. stock may see a shift in December 2025. The expected range spans $172.13–$195.83, with an average target of $183.48. This represents a positive outlook and a possible gain of +0.99%.
January 2026
Analyzing established trends, Krystal Biotech, Inc. looks set to move in January 2026. Projections place the stock between $173.16 and $199.57, averaging around $185.69. This suggests a +2.20% gain from current levels.
February 2026
Market indicators suggest Krystal Biotech, Inc. could experience notable changes during February 2026. Prices could fluctuate within $175.62 to $201.49, with a midpoint forecast of $188.79. The stock might deliver a +3.91% gain.
March 2026
Forecasting for March 2026, models estimate that Krystal Biotech, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $177.39 and $205.10, averaging $192.32. This signals a positive trajectory with potential returns around +5.85%.
April 2026
According to our latest forecast models, Krystal Biotech, Inc. (KRYS) is positioned to show a strong performance in April 2026. The price is predicted to move between $184.05 and $212.41, settling at an average of $198.84. This could translate to a +9.44% gain.
May 2026
Based on current market signals, Krystal Biotech, Inc. is projected to trend may 2026. We forecast a trading range from $186.82 to $209.63, with a likely average price of $197.91. Investors could expect a potential return of +8.93%.
June 2026
Our predictive algorithms indicate Krystal Biotech, Inc. stock may see a shift in June 2026. The expected range spans $187.41–$212.57, with an average target of $200.26. This represents a positive outlook and a possible gain of +10.22%.
July 2026
Analyzing established trends, Krystal Biotech, Inc. looks set to move in July 2026. Projections place the stock between $189.48 and $218.10, averaging around $204.11. This suggests a +12.34% gain from current levels.
August 2026
Market indicators suggest Krystal Biotech, Inc. could experience notable changes during August 2026. Prices could fluctuate within $193.29 to $220.47, with a midpoint forecast of $206.82. The stock might deliver a +13.83% gain.
September 2026
Forecasting for September 2026, models estimate that Krystal Biotech, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $201.74 and $226.60, averaging $213.93. This signals a positive trajectory with potential returns around +17.74%.
October 2026
According to our latest forecast models, Krystal Biotech, Inc. (KRYS) is positioned to show a strong performance in October 2026. The price is predicted to move between $205.13 and $223.98, settling at an average of $214.28. This could translate to a +17.94% gain.
KRYS's history of dividends and stock splits also plays a role in long-term investor confidence.